With the increasing awareness of socio-environmental issues, a global trend has emerged emphasizing the valorization of natural ingredients that promote health and well-being within sustainable production systems, such as microalgae-based carotenoids. Currently, little is understood about the correlation between biomass productivity and carotenoid content, which is a fundamental parameter for facilitating the immediate expansion of microalgae bioprocesses and ensuring the availability and industrial viability of these compounds. In this context, this study aims to investigate the carotenoid profile of Chlorella vulgaris through growth curve experiments conducted under photoautotrophic and heterotrophic regimes. Additionally, a trade-off analysis was performed for the production of carotenoids from microalgae. Carotenoids were quantified using high-performance liquid chromatography coupled with diode array and mass spectrometry detectors (HPLC-PDA-MS/MS). The performance of kinetic phases and energy demands across growth regimes was assessed to provide insights into production trade-offs. The results indicated that a total of 22 different carotenoids were identified in all the extracts. The all-trans-lutein and all-trans-β-carotene were the majority compounds. The total carotenoid content of Chlorella vulgaris revealed significant differences in the kinetic phases of carotenoid production, indicating that carotenoid volumetric production is only viable if the cultures are conducted until the log and stationary phases, based on the function of the biomass volumetric production (weight.volume⁻¹). Therefore, the best trade-off for the process was to provide photoautotrophic growth until the exponential phase (log). Under this condition, the maximum carotenoid and lutein content was 2921.70 µg.L⁻¹, reaching a maximum cell biomass of 1.46 g.L⁻¹. From an environmental/economic point of view, the energy demand was 7.74 kWh.L⁻¹. Finally, the scientific advances achieved in this study provide a holistic view of the influence of the main cultivation methods on the production of microalgae carotenoids, suggesting a viable initial direction for different industrial applications.

This study aimed to investigate the bioaccessibility of carotenoids and chlorophylls from the biomass of microalgae Chaetoceros calcitrans. The samples were submitted to an in vitro digestion protocol, and the compounds were determined by HPLC-PDA-MS/MS. A total of 13 compounds were identified in all tests. After in vitro digestion, the relative bioaccessibility of carotenoids and chlorophylls ranged from 4 to 58%. The qualitative profile of carotenoids reflected the initial sample, with all-E-zeaxanthin (57.2%) being the most bioaccessible compound, followed by all-E-neochrome (31.26%), the latter being reported for the first time in the micellar fraction. On the other hand, among the chlorophylls only pheophytin a (15.01%) was bioaccessible. Furthermore, a chlorophyll derivative (Hydroxypheophytin a’) was formed after in vitro digestion. Considering all compounds, xanthophylls (12.03%) and chlorophylls (12.22%) were significantly (p < 0.05) more bioaccessible than carotenes (11.22%). Finally, the considerable individual bioaccessibilities found, especially for zeaxanthin, demonstrate the bioactive potential of this bioresource. However, the large reduction in the totality of compounds after in vitro digestion suggests that additional technological strategies should be explored in the future to increase the efficiency of micellarization and enhance its bioactive effects.

Cutaneous melanoma (CM) is an aggressive and metastatic tumor, resulting in high mortality rates. Despite significant advances in therapeutics, the available treatments still require improvements. Thus, purinergic signaling emerged as a potential pathway to cancer therapy due to its involvement in cell communication, proliferation, differentiation, and apoptosis. In addition, due to safety and acceptable clinical tolerability, carotenoids from microalgae have been investigated as adjuvants in anti-melanoma therapy. Then, this work aimed to investigate the in vitro anti-melanogenic effect of carotenoid extract (CA) and total biomass (BM) of the Scenedesmus obliquus microalgae on two cutaneous melanoma cell lines (A375 and B16F10). Cells were cultivated under ideal conditions and treated with 10, 25, 50, and 100 μM of CA or BM for 24 h. The effects of the compounds on viability, oxidant status, and purinergic signaling were verified. The IC50 cell viability results showed that CA and BM decreased B16F10 viability at 24.29 μM and 74.85 μM, respectively and decreased A375 viability at 73.93 μM and 127.80 μM, respectively. Carotenoid treatment for 24 h in B16F10 and A375 cells increased the release of reactive oxygen species compared to the control. In addition, CA and BM isolated or combined with cisplatin chemotherapy (CIS) modulated the purinergic system in B16F10 and A375 cell lines through P2X7, A2AR, CD39, and 5′-nucleotidase. They led to cell apoptosis and immunoregulation by activating A2A receptors and CD73 inhibition. The results disclose that CA and BM from Scenedesmus obliquus exhibit an anti-melanogenic effect, inhibiting melanoma cell growth.

Type 2 diabetes mellitus (T2DM) represents a major global public health challenge, and bioactive compounds have been investigated as complementary nutritional strategies for disease management. This study evaluated, for the first time, the effects of carotenoids and chlorophylls (lipophilic extract) of Scenedesmus obliquus on the cecal pigment profile, short-chain fatty acids (SCFAs), metabolic parameters, and intestinal fate in an experimental model of T2DM. Healthy and diabetic Wistar rats were supplemented for 28 days with the lipophilic extract (300 mg/kg body weight), alone or in combination with metformin (150 mg/kg bw). Chlorophyll a and all-trans-lutein were the predominant in the extract, whereas all-trans-lutein and chlorophyll derivatives predominated in the cecal contents. β-Carotene-5,6,5′,8′-diepoxide and porphyrins were detected exclusively in the cecum, indicating extensive metabolic transformations during gastrointestinal digestion. Supplementation significantly reduced blood glucose levels and favorably modulated the SCFA profile, restoring the acetate-to-propionate ratio to values comparable to those of healthy animals. Although total cecal pigment content did not differ among groups, carotenoids and chlorophyll derivatives exhibited distinct accumulation patterns, suggesting differential intestinal metabolism. Overall, the findings indicate that the host metabolic status modulates the intestinal fate of microalgal pigments, supporting their potential contribution to glycemic regulation and intestinal fermentation in T2DM.

This study investigated the cecal distribution of lipophilic pigments (carotenoids and chlorophylls) from Scenedesmus obliquus and their effects on the activity of the intestinal microbiota in rats. Oleoresins containing different concentrations of microalgal pigments (from 0 to 600 µg·kg⁻¹bw·d⁻¹), previously characterized by chromatographic and spectrometric analyses, were administered for four weeks. At the end of the intervention, cecal content samples were collected and analyzed for their pigment composition, short-chain fatty acids (SCFAs), and probiotic microbiota. Nine pigments were identified in the cecal samples, with all-trans-zeaxanthin and pheophytin being the most abundant in all groups. Furthermore, 15-cis-lutein, all-trans-β-cryptoxanthin, and 9-cis-β-carotene—found exclusively in microalgal oleoresin—were detected only in animals receiving doses above 300 µg·kg⁻¹bw.day⁻¹, indicating a link with the SCFA modulation. These supplementations significantly increased the levels of acetate (300 and 450 µg·kg⁻¹bw·d⁻¹ −13% and 14%), butyrate (300 µg kg⁻¹bw·d⁻¹ −19%), and propionate (600 µg·kg⁻¹bw·d⁻¹ −16%). Notably, 300 µg·kg⁻¹bw·d⁻¹ significantly increased Bifidobacterium and Lactobacillus populations. Overall, the pigment supplementation positively influenced the gut microbiota composition and SCFA production in a dose-dependent manner, particularly at 300 µg·kg⁻¹bw·d⁻¹. These results support the potential application of microalgal pigments as functional food ingredients or supplements with gut health benefits.